糖尿病性周围血管病患者血清中TM和EDHF的表达及意义被引量：1

Expression and Significance of Serum Thrombomodulin and Endothelium-Derived Hyperpolarizing Factor in Patients with Diabetic Peripheral Vascular Disease

下载PDF

导出

摘要目的通过观察糖尿病性周围血管病患者血清中TM和EHDF的表达,探讨两者在该病中的意义.方法运用ELISA法检测32例糖尿病性周围血管病组、25例糖尿病组及20例正常组血清中TM与EDHF的表达,统计检测相关数据.结果糖尿病性周围血管病组及糖尿病组分别与正常组比较,两组血清中TM与EDHF明显高于正常组(P<0.01);糖尿病性周围血管病组与糖尿病组、正常组比较,血清中TM与EDHF显著高于后两组(P<0.05).相关性分析结果显示:TM与EDHF在糖尿病各组间血清中表达呈显著性正相关(P<0.01).结论 TM与EDHF参与糖尿病性周围血管病的发病过程,并且两者具有相关性,其可能在该病的发生、发展中起重要作用. Objective To discuss the significance in the disease by observing serum TM and EHDF expressions in patients with diabetic peripheral vascular disease. Methods TM in serum and EDHF expressions of 32 cases with diabetic peripheral vascular disease,25 cases with diabetes and 20 cases with healthy people were detected with ELISA methods,and the data were analyzed statistically. Results Serum TM and EDHF contents of patients in diabetic peripheral vascular disease and diabetic groups were significantly higher than those in the normal group,respectively（P〈0. 01）;those in diabetic peripheral vascular disease group were significantly higher than those in the diabetic group and the normal group（P〈0. 05）. The correlation analysis results showed that the expression of TM and EDHF in serum between diabetes group was significantly positive correlation（P〈0. 01）. Conclusion TM and EDHF may be involved in the pathogenesis of diabetic peripheral vascular disease and there may be a correlation between them,which may play an important role in the occurrence and development of the disease.

作者孙琳

机构地区北华大学附属医院

出处《北华大学学报（自然科学版）》 CAS 2014年第5期623-625,共3页 Journal of Beihua University（Natural Science）

基金吉林省教育厅科学技术研究项目(2012494)

关键词糖尿病糖尿病性周围血管病 TM EDHF diabetes mellitus diabetic peripheral vascular disease thrombomodulin endothelium-derived hyperpolarizing factor

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献8

1耿静,宋敏,葛志明.糖尿病心肌病的研究进展[J].中国心血管病研究,2007,5(6):468-471. 被引量：23
2李翠玲,李金玲,谭红香.糖尿病患者血浆TM和TAT变化的临床意义[J].中国乡村医药,2004,11(10):48-48. 被引量：2
3Rinno H, Kuramoto 1, Ijima T, et al. Measurement of Soluble Thrombomodulin in Sera from Various Clinical Stages of Diabetic Nephropathy [ J ]. Clin Lab Anal, 1996, 10(3) :119-124.
4张强,卢兴国,黄连生,谷卫,吴华香,宋作珪.血浆血栓调节蛋白与糖尿病血管病变的关系[J].临床内科杂志,2000,17(4):223-224. 被引量：14
5Suzuki. Fleming I Cytochrome P450 Epoxygenases as EDHF Synthase (s) [ J ]. Pharmacol Res, 2004,49 ( 6 ) : 525 -533.
6Feletou M, Vanhoutte P M. Endothelial Dysfunction: A Novel Therapeutic Target, the Alternative: EDHF [ J ]. J Mol Cell Cardio1,1999,31 (1) :15 -22.
7Shimokawa H,Yasutake H,Fujii K,et al. The Importance of the Hyperpolarizing Mechanism Increases as the Vesse Size Decreases in Endothelium-Dependent Relaxations in Ratmesenteric Circulation [ J ]. J Cardiovasc Pharmacol, 1996,28:703-711.
8Brandes R P,Schmitz-Winnenthal F H, Feletou M,et al. An Endothelium-Derived Hyperpolarizing Factor Distinct Fromno and Prostacyclin is a Major Endothelium-Depend- ent Vasodilator in Resistance Vessels of Wild-Type and Endothelial NO Synthase Knockout Mice [ J ]. Proc Natl Acad Sci USA,2000,97:9747-9752.

二级参考文献36

1[3]Esmon CT. The role of protein C and throm-bomodulin in the regulation of blood coagulation. J Biol chem, 1989,264:4743～4746
2[4]Boffa MC, Karmochkine M, Berard M, et al. Plasma thrombomodulin as a marker of endothelium damage.Now Rev FrHematol, 1991,33 : 529～ 530
3[1]Asbun J,Villarreal FJ.The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy.Am Coll Cardio,2006,47:693-700.
4[2]Sharma V,McNeill JH.Diabetic cardiomyopathy:where are we 40 years later? Can J Cardiol,2006,22:305-308.
5[3]De Flines J,Scheen AJ.Diabetes mellitus and congestive heart failure:physiopathology and treatment.Rev Med Suisse,2006,2:1893-1896,1898-1900.
6[4]Shen X,Zheng S,Thongboonkerd V,et al.Cardiac mitochondrial damage and biogenesis in a chronicmodel of type 1 diabetes.Am J Physiol Endocrinol Metab,2004,287:E896-E905.
7[5]Fiordaliso F,Bianchi R,Staszewsky L,et al.Antioxidant treatment attenuates hyperglycemia-inducedcardiomyocyte death in rats.J Mol Cell Cardiol,2004,37:959-968.
8[6]Bell DS.Diabetic cardiomyopathy.Diabetes Care,2003,26:2791-2795.
9[7]Golfman LS,Wilson CR,Sharma S,et al.Activation of Ppargamma enhances myocardial glucose oxidation and improves contractile function in isolated woking hearts of ZDF rats.Am J Physiol Endocrinol Metab,2005,289:E328-E336.
10[8]Shiomi T,Tsutsui H,Ikeuchi M,et al.Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction.Am Coll Cardiol,2003,42:165-172.